MAIA Biotechnology | Investor Presentation Deck | 31 slides · page 11 of 31
The slide outlines a multi-part clinical trial process from Part A (Safety) through Part B (Efficacy/Dose Selection) to a planned Expansion phase.
Pitch deck · roadmap · plan_implementation · dense density
Slide locked Sign in to view
Slide schematic 5/5
diagram 1/1 source-note 1/1 subtitle 1/1 table 1/1 title 1/1
Components 5
process source-note subtitle data headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1